John H Weiland insider trades: Celgene (CELG) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
42 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 7, 2018 | CELG | ↑ Buy | 5,575 | $89.73 | $500K | Direct | Aug 7, 2018 (0d) |
| Nov 7, 2017 | BCR | ↓ Sell | 33,435 | $333.31 | $11.1M | Direct | Nov 9, 2017 (2d) |
| Feb 14, 2017 | BCR | ↓ Sell | 14,091 | $240.49 | $3.4M | Direct | Feb 15, 2017 (1d) |
| Feb 13, 2017 | BCR | ↓ Sell | 1,274 | $240.00 | $306K | Direct | Feb 14, 2017 (1d) |
| Feb 9, 2017 | BCR | ↓ Sell | 14,281 | $239.54 | $3.4M | Direct | Feb 10, 2017 (1d) |
| Dec 12, 2016 | BCR | ↓ Sell | 11,190 | $219.67 | $2.5M | Direct | Dec 14, 2016 (2d) |
| Feb 17, 2016 | BCR | ↓ Sell | 1,618 | $187.45 | $303K | Direct | Feb 18, 2016 (1d) |
| Feb 12, 2016 | BCR | ↓ Sell | 15,632 | $182.86 | $2.9M | Direct | Feb 16, 2016 (4d) |
| Feb 9, 2016 | BCR | ↓ Sell | 8,898 | $181.10 | $1.6M | Direct | Feb 10, 2016 (1d) |
| Dec 16, 2015 | BCR | ↓ Sell | 19,686 | $188.49 | $3.7M | Direct | Dec 17, 2015 (1d) |
| Dec 14, 2015 | BCR | ↓ Sell | 33,569 | $184.25 | $6.2M | Direct | Dec 16, 2015 (2d) |
| Feb 19, 2015 | BCR | ↓ Sell | 8,413 | $174.99 | $1.5M | Direct | Feb 20, 2015 (1d) |
| Feb 17, 2015 | BCR | ↓ Sell | 13,616 | $174.51 | $2.4M | Direct | Feb 18, 2015 (1d) |
| Dec 16, 2014 | BCR | ↓ Sell | 23,093 | $166.74 | $3.9M | Direct | Dec 17, 2014 (1d) |
| Dec 9, 2014 | BCR | ↓ Sell | 6,350 | $170.32 | $1.1M | Direct | Dec 10, 2014 (1d) |
| Sep 10, 2014 | BCR | ↓ Sell | 27,179 | $149.50 | $4.1M | Direct | Sep 11, 2014 (1d) |
| Feb 14, 2014 | BCR | ↓ Sell | 73,386 | $138.67 | $10.2M | Direct | Feb 18, 2014 (4d) |
| Feb 11, 2014 | BCR | ↓ Sell | 9,328 | $135.32 | $1.3M | Direct | Feb 12, 2014 (1d) |
| Jan 16, 2014 | BCR | ↓ Sell | 81,500 | $136.13 | $11.1M | Direct | Jan 17, 2014 (1d) |
| Dec 10, 2013 | BCR | ↓ Sell | 10,389 | $137.30 | $1.4M | Direct | Dec 11, 2013 (1d) |
| Oct 23, 2013 | BCR | ↓ Sell | 60,210 | $134.01 | $8.1M | Direct | Oct 24, 2013 (1d) |
| Oct 21, 2013 | BCR | ↓ Sell | 84,525 | $125.62 | $10.6M | Direct | Oct 22, 2013 (1d) |
| Aug 13, 2013 | BCR | ↓ Sell | 5,537 | $116.16 | $643K | Direct | Aug 14, 2013 (1d) |
| Aug 1, 2013 | BCR | ↓ Sell | 87,336 | $115.35 | $10.1M | Direct | Aug 2, 2013 (1d) |
| Mar 7, 2013 | BCR | ↓ Sell | 10,800 | $99.52 | $1.1M | Direct | Mar 11, 2013 (4d) |
| Aug 15, 2012 | BCR | ↓ Sell | 15,554 | $98.42 | $1.5M | Direct | Aug 17, 2012 (2d) |
| May 8, 2012 | BCR | ↓ Sell | 73,806 | $100.13 | $7.4M | Direct | May 9, 2012 (1d) |
| May 3, 2012 | BCR | ↓ Sell | 6,522 | $100.03 | $652K | Direct | May 4, 2012 (1d) |
| May 1, 2012 | BCR | ↓ Sell | 7,447 | $100.01 | $745K | Direct | May 3, 2012 (2d) |
| Mar 5, 2012 | BCR | ↓ Sell | 8,789 | $92.91 | $817K | Direct | Mar 5, 2012 (0d) |
| Aug 16, 2011 | BCR | ↓ Sell | 7,427 | $90.91 | $675K | Direct | Aug 17, 2011 (1d) |
| Aug 9, 2011 | BCR | ↓ Sell | 8,085 | $88.43 | $715K | Direct | Aug 10, 2011 (1d) |
| Mar 29, 2011 | BCR | ↓ Sell | 109,720 | $96.88 | $10.6M | Direct | Mar 30, 2011 (1d) |
| Mar 1, 2011 | BCR | ↓ Sell | 11,442 | $97.32 | $1.1M | Direct | Mar 3, 2011 (2d) |
| Aug 9, 2010 | BCR | ↓ Sell | 14,433 | $80.70 | $1.2M | Direct | Aug 11, 2010 (2d) |
| Mar 1, 2010 | BCR | ↓ Sell | 12,033 | $83.85 | $1.0M | Direct | Mar 2, 2010 (1d) |
| Sep 1, 2009 | BCR | ↓ Sell | 36,590 | $80.51 | $2.9M | Direct | Sep 2, 2009 (1d) |
| Jul 31, 2008 | BCR | ↓ Sell | 151,540 | $93.09 | $14.1M | Direct | Aug 1, 2008 (1d) |
| Feb 27, 2008 | BCR | ↓ Sell | 25,667 | $95.37 | $2.4M | Direct | Feb 28, 2008 (1d) |
| May 2, 2007 | BCR | ↓ Sell | 223,900 | $82.78 | $18.5M | Direct | May 3, 2007 (1d) |
| Apr 30, 2007 | BCR | ↓ Sell | 49,400 | $83.33 | $4.1M | Direct | May 2, 2007 (2d) |
| Apr 28, 2006 | BCR | ↓ Sell | 64,768 | $74.53 | $4.8M | Direct | May 2, 2006 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About John H Weiland's insider trades
John H Weiland is an insider at Celgene (CELG). Since Apr 28, 2006, John has reported 1 open-market purchase worth $500K and 41 sales worth $176.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (89 filings), shares withheld for taxes (30 filings), option exercises (20 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CELG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.